Sarepta Therapeutics Inc (SRPT) — Cash Flow Reinvestment Rate
Sarepta Therapeutics Inc (SRPT) has a Cash Flow Reinvestment Rate of 1.16x as of December 2025, reinvesting $151.71 Million (capex $5.83 Million plus investments $-145.88 Million) from operating cash flow of $131.21 Million. Check Sarepta Therapeutics Inc (SRPT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sarepta Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Sarepta Therapeutics Inc across 1 annual periods. Explore Sarepta Therapeutics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Sarepta Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Sarepta Therapeutics Inc. For live market cap and broader valuation context, see Sarepta Therapeutics Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.11x | $226.29 Million | $107.47 Million | $82.20 Million | — |